Adrian XH
AICAR made sedentary mice run 44% farther. In healthy men, it didn’t measurably switch on the muscle enzyme it’s famous for. This page covers the mouse study, the human studies of AICAR and of the same molecule as the drug acadesine, and why Cardarine isn’t the alternative. Quick takeaways Question What the evidence shows Is …
The best-supported peptides for arthritis are oral collagen products, mainly UC-II (undenatured type II collagen) at 40 mg a day for knee osteoarthritis. For rheumatoid arthritis, no peptide replaces standard treatment. BPC-157 and thymosin alpha-1 are not FDA-approved and have almost no human arthritis data. This guide splits the answer by arthritis type, because osteoarthritis …
Research use only. Nothing on this page is medical advice, and pinealon isn’t approved for human use. Pinealon is the tripeptide Glu-Asp-Arg (EDR) from Vladimir Khavinson’s group. No randomized trial has tested it in people. The evidence is cell work, rodent and monkey studies, and small uncontrolled Russian reports. In the one study with lab …
Research use only. Nothing on this page is medical advice, and no bioregulator peptide is FDA-approved. Bioregulator peptides are short peptides developed by Vladimir Khavinson’s institute in St. Petersburg. Some are extracts from animal organs, and some are lab-made chains of 2 to 4 amino acids (1). What the evidence shows: Jump to the organ …
GLP-1 drugs such as semaglutide and tirzepatide have the best evidence for women’s weight loss, and they work across menopause stages. Two bone drugs and one libido drug also have trials in women. Most other peptides pitched to women, including collagen, GHK-Cu, tesamorelin and sermorelin, don’t have the evidence the pitch claims. Below: what has …
Most of the evidence behind the energy claims on peptides comes from mice, cell studies and company press releases. So here is what each compound actually has. No controlled human trial cited on this page shows a peptide raising energy. Some have hormone-level data. One has an FDA approval for a rare disease. The rest …